Replies to post #4088 on Biotech Values

[DewDiligence]

Statin trials have been designed to demonstrate plaque stability rather than regression. That’s why those trials have measured the change in plaque volume relative to the change on placebo –not relative a patient’s own baseline reading as in the AGIX trial.

>> P.S. Some racy ads at i-hub! Looking at an ad for the "hottest" dating site! <<

If you sign up for a paid iHub membership, you won’t have to see those ads :-)

[Skeptic]

"As I said, as far as I know, the only statin to show regression in other trials has been 80mg lipitor."

I believe 80mg lipitor was the control.